pargyline has been researched along with Hyperprolactinaemia in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koike, K | 1 |
| Miyake, A | 1 |
| Aono, T | 1 |
| Sakumoto, T | 1 |
| Ohmichi, M | 1 |
| Yamaguchi, M | 1 |
| Tanizawa, O | 1 |
1 other study available for pargyline and Hyperprolactinaemia
| Article | Year |
|---|---|
Effect of prolactin on the secretion of hypothalamic GnRH and pituitary gonadotropins.
Topics: Animals; Calcimycin; Calcium; Catecholamines; Dopamine; Dose-Response Relationship, Drug; Female; Fo | 1991 |